Fulgent Genetics, Inc.

22.64 USD
+0.53 (+2.40%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fulgent Genetics, Inc. stock is up 11.2% since 30 days ago. The next earnings date is Aug 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 May’s closed higher than April.

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. provides COVID-19, molecular diagnostic, and genetic testing services in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests for the detection of SARS-CoV-2.